Skip to main content
. 2022 Jul 8;12:909731. doi: 10.3389/fcimb.2022.909731

Figure 1.

Figure 1

Clinical manifestations of P. aeruginosa infections. Representation of human body site infections and main clinical manifestations of P. aeruginosa. Healthcare-associated infections highlighted in blue illustrate the significant burden of P. aeruginosa on invasive acts, surgery, and device use, resulting in local or systemic complications (Wu et al., 2011; Dando et al., 2014; Gahlot et al., 2014; Elborn, 2016; Durand, 2017; Newman et al., 2017; Arsovic et al., 2020; Ramireddy et al., 2020; Chai and Xu, 2020; Shukla et al., 2020; Jean et al., 2020; Montravers et al., 2020; Cerioli et al., 2020; Shrestha et al., 2021; Vieira et al., 2016; Hauser and Ozer, 2011).